ORGANIGRAM GLOBAL INC.
No SEC Form 4 filings for $OGI in the last 30 days.
See all $OGI insider activity →Organigram Global Inc. (NASDAQ: OGI, TSX: OGI) said it will release third-quarter fiscal 2026 results for the quarter ended June 30, 2026 on Aug. 11, 2026 before market open. The company will hold a conference call at 8:00 a.m. ET, with a webcast and replay available on its investor site.
Organigram Global Inc. (OGI) provided a business update on its April 15, 2026 acquisition of Sanity Group. It said Sanity has held about 10% average Germany market share and met revenue expectations, with German reimbursement changes expected to be immaterial. In Canada, OGI reported 11.1% recreational market share and category leadership in flower (12.5%) and vapes (14.5%). Q3 results are due around Aug 11, 2026.
Organigram Global Inc (NASDAQ:OGI) reported March-quarter results on May 12. Net revenue fell 9% YoY to $59.8M and adjusted EBITDA was $0.9M versus $4.9M a year earlier, citing weakness in vapes, pre-roll production issues, and slower industry growth. The company raised 2026 revenue guidance to $350M from $300M, expecting Sanity Group (acquired end of March) to add about €25M quarterly revenue.
Over the past 7 days, alphai's AI scored 1 news story mentioning OGI (ORGANIGRAM GLOBAL INC.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent OGI coverage spans financial news, earnings and market movers.
This is a pre-earnings scheduling update, setting a clear catalyst date for volatility around OGI’s upcoming Q3 print.
Near-term focus is whether the June market-share stabilization and Sanity operating consistency translate into stronger Q3 consolidated numbers.
Guidance raise plus acquisition read-through improves 2H26 growth visibility, offsetting recent March-quarter revenue/EBITDA declines.
Organigram Holdings (OGI) is recommended for purchase based on recent acquisition of Sanity Group GmbH, which enhances its position in European markets. The analyst maintains a 'Buy' rating with a $3.25 target, expecting revenue and EBITDA growth in fiscal years 2026 and 2027.
The ISS recommendation to approve Organigram's acquisition of Sanity Group GmbH suggests a positive outlook for the company's growth prospects, potentially leading to increased market share and diversification. The deal's structure indicates confidence in Sanity’s future performance, which could enhance Organigram's valuation.
alphai scores every news story that mentions OGI with an AI model for sentiment and relevance, and aggregates insider trades from ORGANIGRAM GLOBAL INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Organigram Global Inc. (NASDAQ: OGI, TSX: OGI) said it will release third-quarter fiscal 2026 results for the quarter ended June 30, 2026 on Aug. 11, 2026 before market open. The company will hold a conference call at 8:00 a.m. ET, with a webcast and replay available on its investor site.
2 min readOrganigram Global Inc. (OGI) provided a business update on its April 15, 2026 acquisition of Sanity Group. It said Sanity has held about 10% average Germany market share and met revenue expectations, with German reimbursement changes expected to be immaterial. In Canada, OGI reported 11.1% recreational market share and category leadership in flower (12.5%) and vapes (14.5%). Q3 results are due around Aug 11, 2026.
6 min readOrganigram Global Inc (NASDAQ:OGI) reported March-quarter results on May 12. Net revenue fell 9% YoY to $59.8M and adjusted EBITDA was $0.9M versus $4.9M a year earlier, citing weakness in vapes, pre-roll production issues, and slower industry growth. The company raised 2026 revenue guidance to $350M from $300M, expecting Sanity Group (acquired end of March) to add about €25M quarterly revenue.
5 min readHaywood analyst Neal Gilmer recommends Organigram Holdings, maintaining a "Buy" rating and a $3.25 price target, following its acquisition of Sanity Group GmbH. This acquisition establishes Organigram as a key player in the German and European cannabis markets, complementing its leadership in Canada. The deal is expected to significantly boost Organigram's revenue and Adjusted EBITDA in fiscal years 2026 and 2027, as Gilmer raised his forward estimates.
3 min readInstitutional Shareholder Services Inc. (ISS) has recommended that Organigram Global Inc. shareholders approve the company's proposed acquisition of Sanity Group GmbH. The acquisition is seen as a strategic move to increase scale, diversification, and market presence, with Organigram maintaining a strong financial position. The deal involves an upfront payment of €113.4 million in cash and shares, with potential earn-outs based on Sanity's future performance.
3 min readFour cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.
4 min readOrganigram Global Inc ( NASDAQ: OGI ) shares are trading sharply higher Monday afternoon, joining a rally across the cannabis sector. The surge follows a social media post from President Donald Trump over the weekend, in which he promoted the potential health benefits of cannabis and signaled ...
2 min readQ3 net sales up 72% to $51.14 million, beating $48.33 million estimate. Boosts synergy target from Motif acquisition to $15 million annually. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday → Cannabis grower Organigram Holdings Inc.
3 min readLarge global tobacco companies have made small investments in the cannabis space. Industry experts break down what could be next and why investments have been conservative to date. Get access to the leaderboards pointing to tomorrow's biggest stock movers.
3 min readGlobal Compliance FUAPF shares closed up 54.00% at $0.00 4Front Ventures FFNTF shares closed up 33.33% at $0.00 CordovaCann LVRLF shares closed up 31.39% at $0.06 iAnthus Capital Hldgs ITHUF shares closed up 25.71% at $0.00 Leafbuyer Techs LBUY shares closed up 23.35% at $0.03
3 min read
